Truist reiterates Buy on Universal Technical Institute stock at $38

Truist Securities reiterated a Buy rating on Universal Technical Institute (UTI) with a $38 price target, citing potential upside if execution improves. UTI stock is near its 52-week low, down 48% over six months. The company reported a 7.2% revenue increase in Q3 but missed forecasts and lowered its full-year outlook, leading Texas Capital to downgrade the stock to Hold with a $25 target.

Original reporting
Published Oct 6, 2026, 10:12 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 10:27 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$UTI
Bullish
medium confidence
Mentioned
$UTI
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$UTIBullishLow
01

Why it matters

The analyst upgrade provides a modest catalyst but is offset by ongoing operational concerns.

02

Market read

A small analyst upgrade that may generate limited buying interest in UTI.

03

What to watch

High‑school recruitment challenges remain a material risk to future enrollment growth.

Relevance 4/10Novelty 2/10Timing: today

Background

Truist's reiteration follows a recent Q3 earnings release and a downgrade by Texas Capital due to recruitment channel issues.

Company-level read

Ticker impact

$UTIBullishMedium confidence
Context

Truist reiterated a Buy on Universal Technical Institute with a $38 price target after the company's Q4 guidance and enrollment results.

Expected impact

likely upward pressure as the $38 target suggests near‑term upside.

Evidence & confidence

Analyst upgrade and higher price target can attract buying interest, but recent guidance weakness tempers the move.

Market effects

May slightly improve sentiment for for‑profit education stocks.

Limited to U.S. markets where UTI trades.

Low

Counterpoint

The downgrade by Texas Capital and reduced outlook could outweigh the Truist upgrade.

Key entities

  • Universal Technical Institute

    For‑profit technical education provider (NYSE:UTI).

  • Truist Securities

    Investment bank issuing the Buy rating and $38 target.

Related articles

$UTIHighAI 9/10

Universal Technical Institute falls on weak guidance

Universal Technical Institute (UTI) reported Q4 earnings of $0.32 per share, missing estimates of $0.52. Revenue rose 6.0% to $235.9M, slightly beating expectations. Fiscal 2027 guidance was below expectations, with EPS projected at $0.00 to $0.09. The company attributed the decline to strategic growth investments. Shares fell 10% in after-hours trading.

$UTIMed

Universal Technical Institute Reports Fiscal Year 2026 Fourth Quarter and Year-End Results

UNIVERSAL TECHNICAL INSTITUTE INC (UTI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Universal Technical Institute Reports Fiscal Year 2026 Fourth Quarter and Year-End Results Company Unveils Next-Generation UTI Campus, Skilled Trades Max, and Details Plan for Up to 12 New Campuses and Approximately 45 New Programs for Fiscal 2027 Through Fiscal 2029

$UTILow

Why Universal Technical Institute Stock Zoomed 10% Higher Today

Universal Technical Institute (UTI) shares rose 10% on Monday without company-specific news. The increase followed Lincoln Educational Services' (LINC) Q3 report, showing 13% revenue growth and 24% net profit increase. LINC cited a U.S. skilled trades worker shortage as a key factor. UTI is set to report Q4 earnings on Nov. 18, with analysts expecting 5% revenue growth to $235M and 57% EPS increase to $0.36.